Functional Dyspesia
- PMID: 32921764
- PMCID: PMC7716988
- DOI: 10.23750/abm.v91i3.10150
Functional Dyspesia
Abstract
Dyspepsia is a functional GI disorder consisting in a wide range of symptoms. The main diagnostic challenge has been whether to perform an EGD or an abdominal US in order not to miss organic lesions, but to avoid unnecessary and sometimes invasive tests. Pepsinogen serology has been proposed as an useful non-invasive test to explore the status of the gastric mucosa, suggesting this strategy as an adequate approach in management of dyspepsia. In a primary care setting, 266 dyspeptic patients were investigated to establish the proper diagnosis. The workup included upper GI endoscopy with biopsies, a structured questionnaire including type and severity of symptoms, serological determination of serum pepsinogens, gastrin 17 and IgG against Hp. Inclusion criteria were dyspeptic symptoms (epigastric pain, nausea and/or vomiting, post prandial fullness, early satiation) lasting more than 1 year and the association between symptoms and food ingestion.. Helicobacter pylori infection was present in 114 subjects, characterized by high levels of pepsinogen II and IgG against Hp. Twenty subjects were classified according with the diagnosis of chronic body atrophic gastritis. Nausea and post prandial fullness were the most frequent symptoms (48% and 41%, respectively) in the studied population, followed by epigastric pain and early satiation (37% and 26% respectively). A diagnosis of normality by serological diagnosis was found in half of patients experiencing epigastric pain and in about 60% of subjects with the three other symptoms (nausea, post prandial fullness, and early satiation). In conclusion, this experience confirms the clinical usefulness of serology in dyspepsia, contributing to correctly diagnosing CAG and H.p. infection in such patients and providing a good correlation with the clinical picture.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article
Similar articles
-
Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.Dig Liver Dis. 2005 Jul;37(7):501-8. doi: 10.1016/j.dld.2005.01.016. Epub 2005 Apr 18. Dig Liver Dis. 2005. PMID: 15975537
-
Usefulness of Serum Pepsinogen I as a Biomarker in Early Diagnosis of Aetiology of Dyspepsia.West Afr J Med. 2023 May 27;40(5):509-518. West Afr J Med. 2023. PMID: 37246939
-
Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy.Helicobacter. 2001 Sep;6(3):216-24. doi: 10.1046/j.1523-5378.2001.00031.x. Helicobacter. 2001. PMID: 11683924
-
Recent Advances in the Definition and Management of Functional Dyspepsia.Keio J Med. 2021 Mar 25;70(1):7-18. doi: 10.2302/kjm.2020-0006-OA. Epub 2020 Jul 1. Keio J Med. 2021. PMID: 32612016 Review.
-
Functional dyspepsia: a pragmatic approach.Rom J Intern Med. 2010;48(1):9-15. Rom J Intern Med. 2010. PMID: 21180236 Review.
Cited by
-
Barrett's esophagus: results from an Italian cohort with tight endoscopic surveillance.Acta Biomed. 2022 Mar 14;93(1):e2022130. doi: 10.23750/abm.v93i1.11987. Acta Biomed. 2022. PMID: 35315405 Free PMC article.
-
Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial.Nat Commun. 2024 Jan 3;15(1):227. doi: 10.1038/s41467-023-44292-x. Nat Commun. 2024. PMID: 38172093 Free PMC article. Clinical Trial.
References
-
- Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional Gastroduodenal Disorders Gastroenterology. 2006 Apr;130(5):1466–79. - PubMed
-
- Stanghellini V., F.K., W. L, et al. Gastroduodenal Disorders. Gastroenterology. 2016 May;150(6):1380–92. - PubMed
-
- Malfertheiner P, Megraud F, O’Morain C, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report. Gut. 2017;66:6–30. - PubMed
-
- Tack J, Talley J.N, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466–1479. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous